U.S. Congress eyes short-term funding measure as COVID-19, omnibus talks continue
Reuters
Published Dec 07, 2020 12:35PM ET
Updated Dec 07, 2020 01:10PM ET
WASHINGTON (Reuters) - The U.S. Congress is likely to consider a one-week funding measure to provide additional time for negotiations aimed at hammering out a new COVID-19 relief package and a $1.4 trillion omnibus spending bill, a Democratic congressional aide said on Monday.
Lawmakers in the Senate and House of Representatives face a deadline on Dec. 11, when current funding for federal government agencies is due to expire. But neither omnibus nor coronavirus relief negotiations, which are taking place separately, have succeeded in clinching agreements.
House Speaker Nancy Pelosi and Senate Majority Leader Mitch McConnell have said they hope to include the omnibus bill and coronavirus relief in a single legislative package.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.